These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11236794)

  • 1. Stem-cell transplantation for myelofibrosis.
    Deeg HJ; Appelbaum FR
    N Engl J Med; 2001 Mar; 344(10):775-6. PubMed ID: 11236794
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival in young patients with intermediate- / high-risk myelofibrosis: estimates derived from databases for non transplant patients.
    Siragusa S; Passamonti F; Cervantes F; Tefferi A
    Am J Hematol; 2009 Mar; 84(3):140-3. PubMed ID: 19123461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).
    Patriarca F; Bacigalupo A; Sperotto A; Isola M; Soldano F; Bruno B; van Lint MT; Iori AP; Santarone S; Porretto F; Pioltelli P; Visani G; Iacopino P; Fanin R; Bosi A;
    Haematologica; 2008 Oct; 93(10):1514-22. PubMed ID: 18728030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allogeneic hematopoietic cell transplantation versus drugs in myelofibrosis: the risk-benefit balancing act.
    Tefferi A
    Bone Marrow Transplant; 2010 Mar; 45(3):419-21. PubMed ID: 20216545
    [No Abstract]   [Full Text] [Related]  

  • 5. A retrospective comparison of conventional intensity conditioning and reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in myelofibrosis.
    Gupta V; Kröger N; Aschan J; Xu W; Leber B; Dalley C; Sabloff M; Lipton JH; Messner H; Brune M
    Bone Marrow Transplant; 2009 Sep; 44(5):317-20. PubMed ID: 19234505
    [No Abstract]   [Full Text] [Related]  

  • 6. Allogeneic transplantation: a therapeutic option for myelofibrosis, chronic myelomonocytic leukemia and Philadelphia-negative/BCR-ABL-negative chronic myelogenous leukemia.
    Mittal P; Saliba RM; Giralt SA; Shahjahan M; Cohen AI; Karandish S; Onida F; Beran M; Champlin RE; de Lima M
    Bone Marrow Transplant; 2004 May; 33(10):1005-9. PubMed ID: 15048141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hematopoietic stem cell transplantation for myelofibrosis.
    van Besien K; Deeg HJ
    Semin Oncol; 2005 Aug; 32(4):414-21. PubMed ID: 16202687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stem cell transplantation for myelofibrosis: a report from two Canadian centers.
    Daly A; Song K; Nevill T; Nantel S; Toze C; Hogge D; Forrest D; Lavoie J; Sutherland H; Shepherd J; Hasegawa W; Lipton J; Messner H; Kiss T
    Bone Marrow Transplant; 2003 Jul; 32(1):35-40. PubMed ID: 12815476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Splenectomy after allogeneic haematopoietic stem cell transplantation in patients with primary myelofibrosis.
    Robin M; Espérou H; de Latour RP; Petropoulou AD; Xhaard A; Ribaud P; Socié G
    Br J Haematol; 2010 Sep; 150(6):721-4. PubMed ID: 20618333
    [No Abstract]   [Full Text] [Related]  

  • 10. Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis.
    Kröger N; Thiele J; Zander A; Schwerdtfeger R; Kobbe G; Bornhäuser M; Bethge W; Schubert J; de Witte T; Kvasnicka HM;
    Exp Hematol; 2007 Nov; 35(11):1719-22. PubMed ID: 17976523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised study of allogeneic transplantation with stem cells from blood or bone marrow.
    Heldal D; Tjønnfjord G; Brinch L; Albrechtsen D; Egeland T; Steen R; Solheim BG; Evensen SA
    Bone Marrow Transplant; 2000 Jun; 25(11):1129-36. PubMed ID: 10849524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allogeneic stem cell transplantation as treatment for myelofibrosis.
    Papageorgiou SG; Castleton A; Bloor A; Kottaridis PD
    Bone Marrow Transplant; 2006 Dec; 38(11):721-7. PubMed ID: 17013423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of extensive splenomegaly in patients with myelofibrosis undergoing a reduced intensity allogeneic stem cell transplantation.
    Ciurea SO; Sadegi B; Wilbur A; Alagiozian-Angelova V; Gaitonde S; Dobogai LC; Akard LP; Hoffman R; Rondelli D
    Br J Haematol; 2008 Apr; 141(1):80-3. PubMed ID: 18324970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Allogeneic hematopoietic stem cell transplantation for myelofibrosis.
    Barosi G; Bacigalupo A
    Curr Opin Hematol; 2006 Mar; 13(2):74-8. PubMed ID: 16456372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular remission after allo-SCT in a patient with post-essential thrombocythemia myelofibrosis carrying the MPL (W515A) mutation.
    Rumi E; Passamonti F; Arcaini L; Bernasconi P; Elena C; Pietra D; Brisci A; Arbustini E; Cazzola M; Lazzarino M
    Bone Marrow Transplant; 2010 Apr; 45(4):798-800. PubMed ID: 19734947
    [No Abstract]   [Full Text] [Related]  

  • 16. Allogeneic peripheral blood cell transplantation for hypereosinophilic syndrome with myelofibrosis.
    Vazquez L; Caballero D; Cañizo CD; Lopez C; Hernandez R; Gonzalez I; Flores T; San Miguel JF
    Bone Marrow Transplant; 2000 Jan; 25(2):217-8. PubMed ID: 10673685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Idiopathic myelofibrosis: a retrospective study of 103 patients.
    Anger B; Seidler R; Haug U; Popp C; Heimpel H
    Haematologica; 1990; 75(3):228-34. PubMed ID: 2227619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia].
    Tong XZ; Li J; Tan EX; Zhang GC; Wu XY; Peng AH; Zheng D; Zou WY; Hong WD; Luo SK
    Zhonghua Zhong Liu Za Zhi; 2006 Jul; 28(7):545-8. PubMed ID: 17147125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies of the site and distribution of CD34+ cells in idiopathic myelofibrosis.
    Ni H; Barosi G; Rondelli D; Hoffman R
    Am J Clin Pathol; 2005 Jun; 123(6):833-9. PubMed ID: 15899773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis.
    Kröger N; Zabelina T; Schieder H; Panse J; Ayuk F; Stute N; Fehse N; Waschke O; Fehse B; Kvasnicka HM; Thiele J; Zander A
    Br J Haematol; 2005 Mar; 128(5):690-7. PubMed ID: 15725091
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.